The Business of DNA Nanotechnology: Commercialization of Origami and Other Technologies
School of Engineering, Institute for Bioengineering, University of Edinburgh, The King’s Buildings, Edinburgh, Scotland EH9 3DW, UK
Molecules 2020, 25(2), 377; https://doi.org/10.3390/molecules25020377
Received: 27 November 2019 / Revised: 8 January 2020 / Accepted: 11 January 2020 / Published: 16 January 2020
(This article belongs to the Special Issue Emerging Trend in DNA Nanotechnology)
It is often argued that DNA nanotechnology has a multitude of possible applications. However, despite great advances in the understanding of the fundamental principles of the field, to date, there has been comparatively little commercial activity. Analysis of patent applications and company case studies suggests that this is now starting to change. The number of patent application filings is increasing, and new companies are being formed to exploit technologies based on nanoscale structures and devices made from DNA. There are parallels between the commercial developments in this field and those observed in other areas of innovation. Further commercialization is expected and new players will emerge.
View Full-Text
Keywords:
DNA nanotechnology; DNA origami; patents; commercialization
▼
Show Figures
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
- Supplementary File 1:
PDF-Document (PDF, 615 KB)
MDPI and ACS Style
Dunn, K.E. The Business of DNA Nanotechnology: Commercialization of Origami and Other Technologies. Molecules 2020, 25, 377.
Show more citation formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.


